Project
I6T-MC-AMBI
Completed · 2021 until 2024
Brand Stephan, Smolders Jolijn, Krieger-Grübel Claudia
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2021
End Date
2024
Financing
Industry
Brief description/objective
A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-
Controlled Treat-Through Study of Mirikizumab and Vedolizumab in participants with Moderately to Severely Active Ulcerative Colitis